Literature DB >> 2113034

Indirect inhibition of generation of murine lymphokine-activated killer cell activity in splenocyte cultures by interferon-gamma.

T Y Chao1, H Ohnishi, T M Chu.   

Abstract

The effect of mouse recombinant interferon-gamma (rIFN-gamma) on murine lymphokine-activated killer (LAK) cell activity was investigated using natural killer (NK)-resistant, spontaneously developed, weakly immunogenic and highly tumourigenic, syngeneic murine mammary adenocarcinoma, JC, mimicking that of human disease, as the target. Murine YAC-1 also was used as a target cell line. rIFN-gamma, when used in combination with recombinant interleukin-2 (rIL-2), was shown to exhibit a suppressed effect on LAK cell activity generated from BALB/c mouse splenocytes, compared to that with rIL-2 alone. The decrease in LAK cell activity was rIFN-gamma dose-dependent. Kinetic study revealed that this inhibitory effect was demonstrated only when rIFN-gamma was added to the medium at the early phase of rIL-2 culture. The inhibitory effect on LAK cell generation by rIFN-gamma was completely abrogated when the nylon-wool-treated non-adherent 'macrophage-free' splenocytes were incubated with rIL-2 and rIFN-gamma. These results indicated that the LAK cell activity generated from murine splenocytes cultured with rIL-2 could be depressed by rIFN-gamma, and that the macrophages may be involved as mediators.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2113034      PMCID: PMC1384091     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Characterization and modulation of human lymphokine (interleukin 2) activated killer cell induction.

Authors:  M Hoyer; T Meineke; W Lewis; B Zwilling; J Rinehart
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

2.  Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation.

Authors:  T J Sayers; A T Mason; J R Ortaldo
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

3.  Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).

Authors:  K Itoh; K Shiiba; Y Shimizu; R Suzuki; K Kumagai
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

4.  Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.

Authors:  S Chouaib; K Welte; R Mertelsmann; B Dupont
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

5.  Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

Authors:  M Rosenstein; I Yron; Y Kaufmann; S A Rosenberg
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

6.  Regulation of arachidonic acid metabolism in macrophages by immune and nonimmune interferons.

Authors:  D Boraschi; S Censini; M Bartalini; A Tagliabue
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

7.  Immunotherapy of intraperitoneal cancer with interleukin 2 and lymphokine-activated killer cells reduces tumor load and prolongs survival in murine models.

Authors:  R T Ottow; E P Steller; P H Sugarbaker; R A Wesley; S A Rosenberg
Journal:  Cell Immunol       Date:  1987-02       Impact factor: 4.868

8.  Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells.

Authors:  J C Yang; J J Mulé; S A Rosenberg
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

9.  Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2.

Authors:  L P Svedersky; H M Shepard; S A Spencer; M R Shalaby; M A Palladino
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

10.  Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.

Authors:  A Mazumder; S A Rosenberg
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

View more
  3 in total

1.  Effects of lipopolysaccharide on interleukin-2-induced cytotoxic activity of murine splenocyte cultures: role of prostaglandin E2 and interferons.

Authors:  D Vaillier; R Daculsi; N Gualde
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Induction of lymphokine-activated killer cells from nude mouse spleen cells by interleukin-4.

Authors:  I S Tunru; H Suzuki; M Kobayashi
Journal:  Experientia       Date:  1993-01-15

3.  All-trans retinoic acid decreases susceptibility of a gastric cancer cell line to lymphokine-activated killer cytotoxicity.

Authors:  T Y Chao; S Y Jiang; R Y Shyu; M Y Yeh; T M Chu
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.